Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes

The treatment of acute coronary syndrome (ACS) in elderly patients continues to be a challenge because of the characteS.G.B.ristics of this population and the lack of data and specific recommendations. This review summarizes the current evidence about critical points of oral antithrombotic therapy i...

Descripción completa

Detalles Bibliográficos
Autores: Bonanad, Clara, Esteve Claramunt, Francisca, García Blas, Sergio, Ayesta, Ana, Díez Villanueva, Pablo, Pérez Rivera, Jose-Ángel, Ferreiro, José Luis, Cánoves, Joaquim, López Fornás, Francisco, Ariza Solé, Albert, Raposerias, Sergio, Vivas, David, Blanco, Regina, Bompart Berroterán, Daznia, Cordero, Alberto, Núñez, Julio, Fácila, Lorenzo, Núñez Gil, Iván J., Górriz, José Luis, Bodí, Vicente, Martínez-Sellés D Oliveira Soares, Manuel, Ruiz Nodar, Juan Miguel, Chorro, Francisco Javier
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Universidad Complutense de Madrid (UCM)
Repositorio:Docta Complutense
Idioma:inglés
OAI Identifier:oai:docta.ucm.es:20.500.14352/71726
Acceso en línea:https://hdl.handle.net/20.500.14352/71726
Access Level:acceso abierto
Palabra clave:acute coronary syndrome
elderly
antiplatelet therapy
clopidogrel
prasugrel
ticagrelor
Cardiología
3205.01 Cardiología
Descripción
Sumario:The treatment of acute coronary syndrome (ACS) in elderly patients continues to be a challenge because of the characteS.G.B.ristics of this population and the lack of data and specific recommendations. This review summarizes the current evidence about critical points of oral antithrombotic therapy in elderly patients. To this end, we discuss the peculiarities and differences reported referring to dual antiplatelet therapy (DAPT) in ACS management in elderly patients and what might be the best option considering these population characteristics. Furthermore, we analyze antithrombotic strategies in patients with atrial fibrillation (AF), with a particular focus on those cases that also present coronary artery disease (CAD). It is imperative to deepen our knowledge regarding the management of these challenging patients through real-world data and specifically designed geriatric studies to help resolve the questions remaining in their disease management.

Similares en LA Referencia